Rapport Therapeutics Inc (RAPP)
NASDAQ
Quarter End | Mar 2024 | Jun 2024 |
---|---|---|
USD ($) | USD ($) | |
Total Assets | 206.29M | 346.1M |
Total Current Assets | 198.73M | 340.67M |
Cash and Equivalents | 74.27M | 110.16M |
Total Non-Current Assets | 11.12M | 8.91M |
Total Liabilities | 11.18M | 9.21M |
Total Current Liabilities | 9.89M | 8.1M |
Total Non-Current Liabilities | 1.3M | 1.12M |
Common Equity | 36k | 36k |
Retained Earnings | -68.11M | -86.23M |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Total Assets | 31.6M | 155.42M |
Total Current Assets | 31.27M | 150.87M |
Cash and Equivalents | 31.16M | 70.17M |
Total Non-Current Assets | -10.06M | -25.63M |
Total Liabilities | 12.1M | 14.48M |
Total Current Liabilities | 1.66M | 8.8M |
Total Non-Current Liabilities | 10.44M | 5.68M |
Total Equity | -10.06M | -25.63M |
Common Equity | 31k | 36k |
Retained Earnings | -10.65M | -45.44M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.